Conexeu Sciences Inc. (CNXU)
Nasdaq: CNXU · Orthopedic, Prosthetic & Surgical Appliances & Supplies · filing with the SEC since 2025
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in October.| Fiscal quarter | Q3 FY26 | Q2 FY26 |
|---|---|---|
| Period ending | Jul 31, 2026 | Apr 30, 2026 |
| Report filed | Sep 14, 2026 | Jun 15, 2026 |
| Research and development | 270,412 | 66,605 |
| General and administrative | 34,647 | 16,867 |
| Total operating expenses | 7,688,373 | 2,380,368 |
| Operating income | -7,688,373 | -2,380,368 |
| Interest expense | 0 | 0 |
| Interest and investment income | 34,214 | 84,295 |
| Other income (expense), net | -37,278 | 76,085 |
| Income before income taxes | -7,725,651 | -2,304,283 |
| Income tax expense | 0 | 0 |
| Net income | -7,725,651 | -2,304,283 |
| Earnings per share, basic | -0.29 | -0.11 |
| Earnings per share, diluted | -0.29 | -0.11 |
| Weighted average shares, basic | 26,971,608 | 20,569,664 |
| Weighted average shares, diluted | 26,971,608 | 20,569,664 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Each quarter is three months. A fourth quarter prints only where the company tagged its three months on their own; the whole year is in the annual view.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding